IDEXX Laboratories Stock Soars 15.93% on Strong Earnings
IDEXX Laboratories' stock surged 15.93% in pre-market trading on August 4, 2025, driven by strong second-quarter earnings that exceeded analyst expectations.
The company reported adjusted earnings of $3.63 per share, surpassing estimates of $3.29, while revenue climbed 11% to $1.11 billion. This performance reflects IDEXX Laboratories' robust growth in its diagnostics and veterinary services sectors.
IDEXX Laboratories' strong financial results for the second quarter of 2025 have been a key driver of its stock price surge. The company's earnings per share of $3.63 exceeded analyst estimates of $3.29, while revenue grew by 11% to $1.11 billion. This performance underscores the company's continued strength in the diagnostics and veterinary services markets, where it has a strong presence.

Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet